[go: up one dir, main page]

DOP2006000274A - Formulación de suspensión de fexofenadina - Google Patents

Formulación de suspensión de fexofenadina

Info

Publication number
DOP2006000274A
DOP2006000274A DO2006000274A DO2006000274A DOP2006000274A DO P2006000274 A DOP2006000274 A DO P2006000274A DO 2006000274 A DO2006000274 A DO 2006000274A DO 2006000274 A DO2006000274 A DO 2006000274A DO P2006000274 A DOP2006000274 A DO P2006000274A
Authority
DO
Dominican Republic
Prior art keywords
suspension formulation
fexofenadine suspension
fexofenadine
formulation
suspension
Prior art date
Application number
DO2006000274A
Other languages
English (en)
Inventor
Prafulla Agrawala
Kazimierz Chrzan
Rajiv Haribhakti
Matthew Mermey
Curtis J Porcello
Gary Lee Silvey
Vinh Tran
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38120312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2006000274(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Publication of DOP2006000274A publication Critical patent/DOP2006000274A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
DO2006000274A 2005-12-14 2006-12-06 Formulación de suspensión de fexofenadina DOP2006000274A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75030305P 2005-12-14 2005-12-14

Publications (1)

Publication Number Publication Date
DOP2006000274A true DOP2006000274A (es) 2007-10-15

Family

ID=38120312

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2006000274A DOP2006000274A (es) 2005-12-14 2006-12-06 Formulación de suspensión de fexofenadina

Country Status (38)

Country Link
US (1) US8933097B2 (es)
EP (1) EP1965768B1 (es)
JP (1) JP5308824B2 (es)
KR (1) KR101452792B1 (es)
CN (1) CN101316580B (es)
AR (1) AR058323A1 (es)
AT (1) ATE431137T1 (es)
AU (1) AU2006326551B2 (es)
BR (1) BRPI0619895B1 (es)
CA (1) CA2633086C (es)
CR (1) CR9993A (es)
CY (1) CY1109320T1 (es)
DE (1) DE602006006870D1 (es)
DK (1) DK1965768T3 (es)
DO (1) DOP2006000274A (es)
EC (1) ECSP088532A (es)
EG (1) EG25866A (es)
ES (1) ES2327168T3 (es)
HN (1) HN2008000875A (es)
HR (1) HRP20090411T1 (es)
IL (1) IL192067A (es)
JO (1) JO2549B1 (es)
MA (1) MA30152B1 (es)
MY (1) MY146988A (es)
NO (1) NO339877B1 (es)
NZ (1) NZ568943A (es)
PE (1) PE20071003A1 (es)
PL (1) PL1965768T3 (es)
PT (1) PT1965768E (es)
RS (1) RS51135B (es)
RU (1) RU2405538C2 (es)
SI (1) SI1965768T1 (es)
TN (1) TNSN08186A1 (es)
TW (1) TWI377061B (es)
UA (1) UA89584C2 (es)
UY (1) UY30021A1 (es)
WO (1) WO2007070517A2 (es)
ZA (1) ZA200803985B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101546774B1 (ko) 2008-07-29 2015-08-24 엘지전자 주식회사 휴대 단말기 및 그 동작제어 방법
WO2013058996A1 (en) 2011-10-19 2013-04-25 R.P. Scherer Technologies, Llc Two phase pharmaceutical delivery system
US10130620B2 (en) 2013-07-01 2018-11-20 Aventisub Llc Liquid pharmaceutical composition for oral administration comprising fexofenadine
JP2016523928A (ja) * 2013-07-03 2016-08-12 アール.ピー.シェーラー テクノロジーズ、エルエルシー フェキソフェナジンを有するカプセル製剤
CN103610645B (zh) * 2013-11-25 2016-05-11 浙江万晟药业有限公司 一种非索非那定盐酸盐的药物组合物及制备方法
CN106806346B (zh) * 2015-12-01 2020-09-11 国药集团广东环球制药有限公司 一种非索非那定盐酸盐干混悬剂制剂及其制备方法
WO2017218894A1 (en) 2016-06-16 2017-12-21 Cutispharma, Inc. Composition and method for proton pump inhibitor suspension
JP7169671B2 (ja) 2017-06-02 2022-11-11 テイカ製薬株式会社 難水溶性成分可溶化ミセル及びそれを含有する液剤
US11633478B2 (en) 2019-07-16 2023-04-25 Azurity Pharmaceuticals, Inc. Compositions and kits for Omeprazole suspension
US10751333B1 (en) 2019-07-16 2020-08-25 Cutispharma, Inc. Compositions and kits for omeprazole suspension
WO2022175829A1 (en) 2021-02-17 2022-08-25 Cellix Bio Private Limited Topical formulations and compositions
CN115715759B (zh) * 2022-11-03 2024-01-12 京海盛达(北京)科技有限公司 一种抗组胺混悬剂及其制备方法
KR20250133597A (ko) 2023-01-20 2025-09-08 오펠라 헬스케어 그룹 에스에이에스 파라벤 프리 펙소페나딘 제제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4829064A (en) 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
EP2354125A1 (en) 1994-05-18 2011-08-10 Aventisub II Inc. Anhydrous and hydrate polymorphic forms of antihistaminic piperidine derivatives
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6319513B1 (en) * 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
GB9822170D0 (en) 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
US20040248935A1 (en) 2001-07-31 2004-12-09 Milla Frederico Junquera Fexofenadine polymorph
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
ES2334028T3 (es) * 2003-01-30 2010-03-04 Ethypharm Particulas recubiertas enmascaradoras del sabor, procedimiento para la preparacion de las mismas y comprimidos bucodispersables que contienen dichas particulas recubiertas.
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
DK2377557T3 (en) * 2004-11-24 2017-02-06 Meda Pharmaceuticals Inc Compositions comprising azelastine and methods for its use
MX2008001246A (es) 2005-07-27 2008-03-18 Sandoz Ag Un proceso para la preparacion de compuestos de fenil eter substituidos y rosiglitazona.
WO2007017905A1 (en) * 2005-08-05 2007-02-15 Lupin Limited Oral pharmaceutical suspension compositions of fexofenadine

Also Published As

Publication number Publication date
MY146988A (en) 2012-10-15
TNSN08186A1 (en) 2009-10-30
CN101316580B (zh) 2011-11-16
PL1965768T3 (pl) 2009-11-30
NO20082904L (no) 2008-09-10
EP1965768B1 (en) 2009-05-13
ECSP088532A (es) 2008-08-29
KR20080074180A (ko) 2008-08-12
RU2008128418A (ru) 2010-01-20
ATE431137T1 (de) 2009-05-15
ZA200803985B (en) 2009-03-25
TWI377061B (en) 2012-11-21
IL192067A0 (en) 2009-02-11
MA30152B1 (fr) 2009-01-02
WO2007070517A2 (en) 2007-06-21
PT1965768E (pt) 2009-08-07
EP1965768A2 (en) 2008-09-10
JO2549B1 (en) 2010-09-05
RS51135B (sr) 2010-10-31
US20080299211A1 (en) 2008-12-04
KR101452792B1 (ko) 2014-10-22
UA89584C2 (en) 2010-02-10
AU2006326551B2 (en) 2012-06-07
DK1965768T3 (da) 2009-09-07
BRPI0619895B1 (pt) 2022-04-12
CN101316580A (zh) 2008-12-03
WO2007070517A3 (en) 2007-08-23
JP2009519935A (ja) 2009-05-21
AU2006326551A1 (en) 2007-06-21
US8933097B2 (en) 2015-01-13
BRPI0619895A2 (pt) 2011-10-25
RU2405538C2 (ru) 2010-12-10
UY30021A1 (es) 2007-07-31
HRP20090411T1 (hr) 2010-01-31
AR058323A1 (es) 2008-01-30
SI1965768T1 (sl) 2009-10-31
IL192067A (en) 2010-12-30
JP5308824B2 (ja) 2013-10-09
ES2327168T3 (es) 2009-10-26
CA2633086C (en) 2011-10-18
NO339877B1 (no) 2017-02-13
EG25866A (en) 2012-09-12
HK1123197A1 (en) 2009-06-12
NZ568943A (en) 2010-04-30
TW200812581A (en) 2008-03-16
CA2633086A1 (en) 2007-06-21
CY1109320T1 (el) 2014-07-02
DE602006006870D1 (de) 2009-06-25
HN2008000875A (es) 2012-01-30
PE20071003A1 (es) 2007-10-03
CR9993A (es) 2008-09-23

Similar Documents

Publication Publication Date Title
DOP2006000274A (es) Formulación de suspensión de fexofenadina
ATE408603T1 (de) Pyrazolylcarboxanilide
CR9974A (es) Gavión
DE502006003394D1 (de) Lehnenklappung
DE602006012066D1 (de) Daraus
DE502006005667D1 (de) Gelenklager
ATE549324T1 (de) Tetrahydrobenzoxazine
EP1916896A4 (en) NOT STEROID-antiandrogens
DE602006018502D1 (de) Ng
DE112006002964A5 (de) Zweirichtungsreflektanzverteilungsmessgerät
DE502006004302D1 (de) Verschlusskappe
EP1867636A4 (en) PYRIDYLMETHYLSULFONDERIVAT
DE502006001397D1 (de) Lagerbuchse
DE502006001004D1 (de) Hydrolager
ATE485368T1 (de) Hiv - impfung
DE502006003147D1 (de) Verbundgußplatte
DE502005005839D1 (de) Feldgeerät
DE502006003210D1 (de) Nohydrogenpolysiloxanen
DE502006000445D1 (de) Mulchmähdeck
DE502006000489D1 (de) Induktionshärtungsanlage
DE102006033170A8 (de) Einfassnähmaschine
DE102005052834B8 (de) Punktschweißklebverbindung
AT501523A3 (de) Estrich
DE502006002822D1 (de) Ges
DE602006016754D1 (de) Stabilisator